The International Journal of Innovative Medicine (IJIM) is an international, double-blind peer-reviewed, open-access medical journal dedicated to the dissemination of high-quality research. The journal aims to provide a multidisciplinary platform for researchers, clinicians, and healthcare professionals to share innovative research, clinical studies, and comprehensive reviews that bridge the gap between medical theory, technology, and clinical practice.

Aims & Scope

IJIM is committed to publishing cutting-edge research that contributes to the advancement of medical sciences. The journal welcomes submissions from all fields of medicine, with a special emphasis on studies that introduce new techniques, utilize artificial intelligence in healthcare, or propose innovative solutions to clinical challenges.

Primary areas of interest include, but are not limited to:

• Clinical Medical Sciences: Original research in internal medicine, surgery, pediatrics, and other clinical specialties.

• Basic Medical Sciences: Studies exploring the fundamental mechanisms of disease and therapy.

• Medical Technology & AI: Application of artificial intelligence, machine learning, and biomedical engineering in diagnosis and treatment.

• Translational Medicine: Research that translates scientific discoveries into clinical applications.

• Surgical Innovations: New surgical techniques and interventional procedures.

Publication Frequency

The International Journal of Innovative Medicine is published tri-annually (three times a year). The regular issues are released in April, August, and December. The journal may also publish special issues focused on specific topics or conference proceedings upon the decision of the Editorial Board.

Peer Review Policy

To ensure the highest scientific quality, IJIM adheres to a rigorous double-blind peer-review process. Every manuscript submitted is evaluated by at least two independent expert reviewers. The identities of both the authors and the reviewers are kept anonymous to ensure an unbiased and objective evaluation. The journal follows the ethical guidelines recommended by the Committee on Publication Ethics (COPE).

Open Access Statement

The International Journal of Innovative Medicine is fully open access. We believe that scientific knowledge should be freely accessible to the public to foster global exchange and innovation. All articles published are immediately available to read, download, and share without any subscription fees.

Target Audience

The journal addresses a global audience consisting of medical specialists, general practitioners, academic researchers, biomedical engineers, and healthcare policymakers who are interested in the latest developments in medical science and technology.